IP Library Granted Patent US 9,863,009
Granted Patent B2
US 9,863,009 · App. 14/518,413 · Granted Jan 9, 2018

Sequence specific primer pool for multiplex PCR and method of detecting microbial infections in thalassemia patients

Inventors: Amein Kadhem Al-Ali (Dhahran, SA); Francis Borgio Jesu Alexander (Khobar, SA); Zaki Naserullah (Qatif, SA); Sayed Abdul Azeez (Rakkah, SA); Sana Al-Jarrash (Qatif, SA)
Assignee: University of Dammam
C12Q1/6895C12Q1/689C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,863,009
App. No.
14/518,413
Granted
Jan 9, 2018
Kind
B2
Abstract

Reagents and methods for the fast, accurate and early detection of infections in thalassemia major patients. Reagents include a primer pool containing a mixture of primer pairs for the specific recognition and simultaneous amplification of targeted gene sequences of pathogens from a biological sample collected from a patient in a multiplex PCR reaction. Pathogens may include at least one Fungi species, Klebsiella pneumoniae, Candida albicans and Staphylococcus aureus . Subsequent identification of the pathogens is achieved by DNA sequencing analysis.

Claims (12)

1. A method of detecting infections by multiple pathogens in a human subject diagnosed with or suspected of having thalassemia major, comprising:

(a) isolating total DNA from a biological sample obtained from the human subject;

(b) performing a PCR reaction on the isolated total DNA wherein the PCR reaction comprises a primer pool comprising single-stranded oligonucleotide primer pairs for simultaneous recognition and amplification of DNA sequences of Klebsiella pneumoniae, Candida albicans, Staphylococcus aureus and at least one fungi species; and

(c) determining the nucleotide sequences of PCR amplification products from (b) wherein presence of PCR amplification products from two or more of Klebsiella pneumoniae, Candida albicans, Staphylococcus aureus and/or at least one fungi species is indicative of multiple infection; wherein the primer pairs have the nucleotide sequences of SEQ ID NOS. 1-8.

2. The method of claim 1 , wherein the biological sample is blood, plasma or serum.

3. The method of claim 1 , wherein the biological sample is spinal fluid.

4. The method of claim 1 , wherein the biological sample is synovial fluid.

5. The method of claim 1 , wherein the biological sample is lymph fluid.

6. The method of claim 1 , wherein the biological sample is sputum.

7. The method of claim 1 , wherein the biological sample is urine.

8. The method of claim 1 , wherein the biological sample comprises cells.

9. The method of claim 1 , wherein the biological sample comprises cells from the subject that have been cultured in vitro.

Assignments (2)
CHANGE OF NAME Recorded Mar 22, 2019
From: UNIVERSITY OF DAMMAM
To: IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY
Reel/Frame 048678/0015 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2014
From: AL-ALI, AMEIN KADHEM; ALEXANDER, FRANCIS BORGIO JESU; NASERULLAH, ZAKI; AZEEZ, SAYED ABDUL; AL-JARRASH, SANA
To: UNIVERSITY OF DAMMAM
Reel/Frame 033997/0265 →
Continuity (2)
Provisional Application 62053014 · Sep 19, 2014
Related Publication 20160083806A1 · Mar 24, 2016